Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALNY

Alnylam Pharmaceuticals Inc

May 29 • 04:00PM ET

301.98

-3.08 -1.01 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ARGX REGN VRTX AMGN GILD BIIB BMRN ONC ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX	P/E	71.75	EPS (ttm)	4.21	Insider Own	0.43%	Shs Outstand	133.44M	Perf Week	0.49%
Market Cap	40.32B	Forward P/E	28.31	EPS next Y	10.67	Insider Trans	-11.71%	Shs Float	132.94M	Perf Month	0.26%
Enterprise Value	40.28B	PEG	0.36	EPS next Q	1.63	Inst Own	98.85%	Short Float	4.06%	Perf Quarter	-9.29%
Income	577.22M	P/S	9.40	EPS this Y	221.64%	Inst Trans	0.94%	Short Ratio	4.99	Perf Half Y	-29.74%
Sales	4.29B	P/B	37.47	EPS next Y	42.34%	ROA	12.36%	Short Interest	5.40M	Perf YTD	-24.06%
Book/sh	8.06	P/C	13.40	EPS next 5Y	78.43%	ROE	96.94%	52W High	495.55 -39.06%	Perf Year	3.10%
Cash/sh	22.54	P/FCF	62.87	EPS past 3/5Y	- -	ROIC	15.30%	52W Low	284.28 6.23%	Perf 3Y	60.41%
Dividend Est.	-	EV/EBITDA	49.92	Sales past 3/5Y	52.98% 49.77%	Gross Margin	80.83%	Volatility	3.02% 3.62%	Perf 5Y	112.68%
Dividend TTM	-	EV/Sales	9.40	EPS Y/Y TTM	308.45%	Oper. Margin	17.54%	ATR (14)	10.05	Perf 10Y	346.91%
Dividend Ex-Date	-	Quick Ratio	3.06	Sales Y/Y TTM	82.57%	Profit Margin	13.46%	RSI (14)	51.02	Recom	1.71
Dividend Gr. 3/5Y	- -	Current Ratio	3.13	EPS Q/Q	440.32%	SMA20	2.14%	Beta	0.29	Target Price	441.58
Payout	0.00%	Debt/Eq	2.76	Sales Q/Q	96.43%	SMA50	-2.25%	Rel Volume	2.10	Prev Close	305.06
Employees	2500	LT Debt/Eq	2.51	Earnings	Apr 30 BMO	SMA200	-21.69%	Avg Volume	1.08M	Price	301.98
IPO	May 28, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	73.26% 4.63%	Trades		Volume	2,271,074	Change	-1.01%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)